Shares of Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) were down 4% on Tuesday . The stock traded as low as $19.58 and last traded at $19.58. Approximately 708 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 81,598 shares. The stock had previously closed at $20.40.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. began coverage on shares of Ascentage Pharma Group International in a report on Thursday, March 27th. They set an “overweight” rating on the stock.
Read Our Latest Stock Analysis on Ascentage Pharma Group International
Ascentage Pharma Group International Price Performance
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
See Also
- Five stocks we like better than Ascentage Pharma Group International
- What is an Earnings Surprise?
- Joby Aviation: Operational Momentum vs. Market Sentiment
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Broadcom’s Big Outperformance Shows Strength Amid Tariff Decline
- What Are Dividend Contenders? Investing in Dividend Contenders
- Carvana: Can Turnaround Strength Outdrive Market Headwinds?
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
